Can We Customize Chemotherapy? Individualizing Cytotoxic Regimens in Advanced Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Can We Customize Chemotherapy? Individualizing Cytotoxic Regimens in Advanced Non–Small-Cell Lung Cancer

Published:2008-03 Issue: Volume:9 Page:S76-S82
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Rosell Rafael,Manegold Christian,Moran Teresa,Garrido Pilar,Blanco Remei,Lianes Pilar,Stahel Rolf,Trigo Jose Manuel,Wei Jia,Taron Miquel

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference40 articles.

1. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study [published correction appears in Lancet Oncol 2007; 8:868];Berrino;Lancet Oncol,2007

2. ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy;Metzger;J Clin Oncol,1998

3. ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy;Shirota;J Clin Oncol,2001

4. Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer;Lord;Clin Cancer Res,2002

5. Increased DNA synthesis and repairenzyme expression in lymphocytes from patients with chronic lymphocytic leukemia resistant to nitrogen mustards;Geleziunas;J Natl Cancer Inst,1991

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular tests for prediction of tumor sensitivity to cytotoxic drugs;Cancer Letters;2022-02

2. Using genetics to predict patient response to platinum-based chemotherapy;Expert Review of Precision Medicine and Drug Development;2017-01-02

3. Genomic polymorphisms of SLC29A3 associated with overall survival in advanced non-small-cell lung cancer treated with gemcitabine;Medical Oncology;2014-02-18

4. Biomarkers in lung oncology;Pulmonary Pharmacology & Therapeutics;2010-12

5. Serum cytokine levels in patients with advanced non-small cell lung cancer: correlation with treatment response and survival;Medical Oncology;2010-08-17